Havrix should not be administered to subjects with known hypersensitivity to any component of the vaccine (see Description), or to subjects having shown signs of hypersensitivity after previous administration of Havrix.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
